UP

Axar.Az Logo

AZ RU EN آذ فا
German Chancellor: War affects lives, we want it to end
US Federal Reserve cuts discount rate to 4–4.25%
Latvia extends airspace closure until Oct 8

Cancer immunotherapy drug 'less toxic and prolongs life'

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

An immunotherapy drug that could save some cancer patients from the ordeal of extreme chemotherapy may also help them live longer, researchers say.

Axar.az reports citing BBC.

In a trial, pembrolizumab kept head and neck cancers at bay for an average of two years - five times longer than under chemotherapy.

The patients also suffered far fewer side-effects.

Cases of head and neck cancers are rising in the UK and most are diagnosed late, when they are hard to treat.
Date
2019.11.23 / 21:56
Author
Axar.az
Share
See also

Scientists develop a drug that trains the immune system

Early smoking increases cancer risk up to 4 times

Chikungunya fever is spreading rapidly in South China

Harmanci: COVID-19 still present, caution needed

Millions at risk as US ends AIDS funding - UNAIDS report

Smart hydrogel developed to heal chronic wounds faster

WHO pushes bold reforms, launching 3 by 35 initiative

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Latest
TERMS OF USEAll rights reserved. When using a material link is required. When using the material on the internet pages of the corresponding transition is required.

COMMUNICATION WITH US Baku city, Binagadi district, street S.S.Akhundov
(+994 12) 464-61-74, 464-61-75, 464-61-76
[email protected]
For reklam: [email protected]

www.axar.az - 2025
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla